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Abbreviations 
CBD  Cannabidiol  
EFSA European Food Safety Authority  
EHO Environmental Health Officers  
EU European Union 
FSAI Food Safety Authority of Ireland  
NFC Novel food catalogue  
THC Tetrahydrocannabinol 
 
Relevant Food Law 
 Novel Food: Regulation (EU) 2015/2283 
 Provision of food information to consumers: Regulation (EU) No 1169/2011 (S.I. No 556 
of 2014) 
 General principles and requirements of food law: Regulation (EC) No 178/2002 (S.I. No 
747 of 2007) 
 Food Supplements: Directive 2002/46/EC (S.I. 506 of 2007) 
 Nutrition and Health Claims: Regulation (EC) No 1924/2006 (S.I. No 11 of 2014) 
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Summary 
The Food Safety Authority of Ireland (FSAI) coordinated a survey of foods and food 
supplements on the Irish market that consist of or contain hemp (Cannabis sativa) or hemp-
derived material. Samples were collected by Environmental Health Officers (EHOs) of the 
Health Service Executive and analysed by the Public Analyst laboratory in Dublin for the 
presence of a number of cannabinoids found naturally in hemp. 
Cannabidiol (CBD) is one of more than one hundred cannabinoids found naturally in the hemp 
plant (Cannabis sativa). Unlike the psychoactive cannabinoid Delta-9-Tetrahydrocannabinol 
(∆9-THC), CBD does not cause the euphoric “high” that is commonly associated with the 
consumption of narcotics. CBD is the predominant marketing feature associated with hemp-
derived foods and food supplements placed on the EU market in recent years. As the market 
has expanded rapidly, so too have concerns about the safety, quality and integrity of many of 
the products on sale in Ireland, most of which originate outside of Ireland. 
This FSAI survey has identified a considerable number of regulatory non-compliances with 
respect to EU and Irish food law. Many of the supplements had not been notified to the FSAI 
contrary to legal requirements and a substantial number are considered novel foods which 
require premarket authorisation under EU food law. The level of CBD content of all products 
determined by an accredited laboratory was found to vary considerably from that declared 
on associated packaging or online material. 
∆9-THC was detected in 84% of the products tested. The level of ∆9-THC in 37% of the products 
tested was such that consumption of the maximum stated dosages could result in a significant 
exceedance of the safety limit established by the European Food Safety Authority (EFSA) in 
2015. In addition to the safety risk, the presence of THC in these products also poses a risk to 
consumers who could unwittingly record a positive drug test (THC), potentially jeopardising 
their athletic or professional careers. 
 
Background 
In 2016, the FSAI received two enquiries about the legal status of hemp-based foods and food 
supplements in Ireland and the EU. In 2017, the number of such queries was close to twenty 
and increased to over one hundred in both 2018 and 2019. This increase in the number of 
enquiries to the FSAI about hemp-derived foods and food supplements coincided with the 
rapid expansion in the market for such foods (predominantly food supplements) in Ireland, 
the EU and other parts of the world. While there are no reliable data available about the size 
of the Irish market for CBD products, industry group The Centre for Medicinal Cannabis expect 
it to reach almost £1 billion in the UK by 20251. The hemp plant (Cannabis sativa) is perceived 
as relatively easy to cultivate, with growing interest in Ireland for the many feasible end uses 
and its environmental potential as an efficient carbon sink. 
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The public interest in food and food supplements containing CBD coincides with a relatively 
recent interest in the medicinal use of cannabis and cannabis derivatives for the treatment of 
certain medical conditions such as some severe forms of epilepsy. However, while there is 
some empirical and even scientific evidence supporting the medicinal use of cannabis-based 
products, any evidence of potential health benefits associated with the consumption of foods 
or food supplements containing CBD or hemp oil is largely anecdotal at this time. 
 
Regulatory Status of Hemp and Hemp-Based Foods in 
Ireland and the EU 
Novel food 
A novel food is a food or ingredient that has not been available to a significant degree on the 
EU market prior to May 15, 1997. A novel food must be authorised in accordance with 
Regulation (EU) 2015/2283 before being placed on the EU market. The novel food catalogue2 
(NFC) is an informal, non-legally binding record of the conclusions of discussions that have 
taken place at EU level in relation to the novel food status of different foods. The information 
in the NFC is based on evidence provided to Member States or the Commission about a 
significant history of consumption of certain foods or food ingredients within the EU prior to 
May 15, 1997. The contents of the NFC are amended when new verifiable information 
becomes available. 
The current novel food status of hemp (Cannabis sativa) outlined in the NFC stipulates that; 
“Some products derived from the Cannabis sativa plant or plant parts such as seeds, seed oil, 
hemp seed flour, defatted hemp seed have a history of consumption in the EU and therefore, 
are not novel”. It further clarifies that national legislation in place in some EU Member States 
may restrict the placing on the market of these foods. 
A separate entry in the NFC under “Cannabinoids” stipulates that the hemp plant contains “a 
number of cannabinoids”, including THC and CBD. It goes on to clarify that: “extracts of 
Cannabis sativa L. and derived products containing cannabinoids are considered novel foods 
as a history of consumption has not been demonstrated”. This means that before being 
placed on the EU market, hemp-derived products that have been subjected to extraction with 
solvents like ethanol or CO2 and used in or as foods and food supplements are considered 
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Tetrahydrocannabinol (THC) in food 
Food is defined in “General Food Law” Regulation (EC) No 178/2002, (S.I. No 747 of 2007), 
which also requires that all food placed on the market is safe. THC is specifically designated 
as a psychotropic substance in accordance with Schedules I and II of the United Nations 
Convention on Psychotropic Substances, 1971. Unlike some residues and contaminants, there 
is no tolerance level set for THC in food under EU or Irish food law. 
Controlled Drugs in Ireland 
In Ireland, THC is a controlled drug in accordance with the Misuse of Drugs Act 1977, with no 
threshold or tolerance currently in place. 
Regulation (EU) No 1307/2013 restricts the availability of direct EU farm payments for hemp 
cultivation to those hemp varieties in the Common Catalogue of Varieties of Agricultural Plant 
Species where the level of THC does not exceed 0.2%. Regulation (EU) No 1308/2013 allows 
for the import into the EU of hemp varieties where the level of THC does not exceed 0.2%. 
However, neither of these Regulations apply to food or food supplements and so the 0.2% 
THC tolerance does not apply. 
Safety of Food from Animals Fed Hemp or Hemp-Derived Feed 
Materials Containing THC 
The European Food Safety Authority (EFSA) published a scientific Opinion3 in 2015 on the risks 
for human health related to the presence of the psychoactive ∆9-THC in milk and other food 
of animal origin. EFSA concluded that exposure to ∆9-THC in the diet through milk or dairy 
products from animals fed hemp seed is unlikely to pose a health concern. Since the available 
data was limited, EFSA had to estimate acute dietary exposure by combining different 
scenarios for the presence of ∆9-THC in feed derived from hemp seed. Acute exposure to ∆9-
THC from the consumption of milk and dairy products ranged between 0.001 and 0.03 μg/kg 
bw/day in adults, and 0.006 and 0.13 μg/kg bw/day in toddlers. Accordingly, EFSA estimated 
an Acute Reference Dose for ∆9-THC of 1µg/kg bw. This represents the highest dose of ∆9-THC 
consumed in a sitting or a day that is unlikely to have an adverse effect. 
General food labelling 
A fundamental rule of food labelling in the EU relates to “Fair information practices” as set 
out in Article 7 of Regulation (EU) No 1169/2011 (S.I. No 556 of 2014). This stipulates that 
food information shall not be misleading. For example, it is not permitted to suggest that a 
food possesses special characteristics when in fact all similar foods possess such 
characteristics, particularly emphasising the presence or absence of certain ingredients or 
nutrients. 
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Food supplements 
The placing on the EU market of food supplements is governed by Directive 2002/46/EC as 
amended (S.I. 506 of 2007). As well as a number of labelling requirements, food supplements 
being placed on the Irish market for the first time must be notified using the online 
notification system. Notification is not an authorisation nor is it a confirmation that a food 
supplement complies with EU or Irish food law. 
 
Nutrition and health claims 
Nutrition or health claims may only be associated with foods where they have been 











Objective of the Survey 
The objective of this survey was to determine the regulatory compliance of food and food 
supplements, predominantly in liquid form that claim to contain CBD in Ireland. Compliance 
was checked against the requirements set out in legislation governing novel food, general 
food law, food supplements, general food labelling and health claims legislation. 
Sampling and Analysis 
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Hemp derived foods on the Irish market are predominantly in the form of food supplements 
in liquid form, although the number of general foods claiming to contain CBD is increasing. It 
is difficult to estimate the number of different hemp-based products on the Irish market. 
However, for the purpose of this survey, the number of food samples selected (38) was 
considered representative of the Irish market. 
Samples were collected by Environmental Health Officers across Ireland and sent for analysis 
to the Public Analyst Laboratory in Dublin (PALD). Analysis was based on a method published 
in 2018 by the Shimadzu Corporation4. The Shimadzu method concerned the determination 
of CBD and general cannabinoid content in hemp oils using HPLC with UV detection but was 
substituted by PALD with UPLC chromatographic separation and LC-MS/MS detection. 
In the method adapted by PALD, cannabinoids were extracted from the samples using 
acetone, followed where necessary by centrifugation and dilution. The individual 
cannabinoids were chromatographically separated using a Waters I-Class Ultra-Performance 
liquid chromatography (UPLC) system and detected via a Waters TQ-XS Mass Spectrometry 
instrument. 
The identification of the analytes was performed using both qualification and quantification 
ions. Quality control was performed on every analytical run through the analysis of a Certified 
Reference Material as well as in-house spiked samples. The laboratory regularly participates 
in international external quality assurance and proficiency testing schemes. The method was 
approved for accreditation by INAB in 2019. 
 
Results 
Analytical data presented refers only to the product batches tested. 
• 84% (32/38) of products tested were found to contain the psychotropic substance THC. If 
consumed at the maximum stated dosage, 37% (14/38) of products tested could deliver 
levels of ∆9-THC that would significantly exceed the EFSA acute reference dose of 1µg/kg 
body weight. 
• 34% (13/38) of the samples are considered to be novel foods and require novel food 
authorisation before being placed on the EU market. 
• 41% (15/37) of the products tested contained CBD levels which differed from the declared 
content by ≥50%, (one product did not declare CBD levels). 92% of products differed from 
the declared CBD content by ≥10%. Some products contained trace levels of CBD, despite 
the fact that significant levels were declared on the label. 
• 36% (13/36) of samples that were classed as food supplements had not been notified to 
the FSAI, as required under S.I. No 506 of 2007. 
• 50% (19/38) of the products sampled made various claims either on the packaging or on 
associated online material. These claims included unauthorised nutrition or health claims, 
possible medicinal claims and misleading lactose free, gluten free and non-GMO claims. 
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Information provided on two products was not in the English language as required under 
S.I. No 556 of 2014. 
 
Conclusions 
Some of the results of this national survey are similar to those reported in 2019 by the Centre 
for Medicinal Cannabis in the UK1 in terms of the presence of THC and the declared levels of 
CBD. The difference between this survey of the Irish market and other recent reports from 
different countries is the level of detail examined and the fact that the results of this survey 
form the basis for corrective action to be coordinated by the FSAI and the Health Service 
Executive in Ireland. 
All of the food products analysed in this survey were found to have one or a number of 
regulatory issues that need to be addressed with the responsible food businesses. Novel 
foods must be authorised before being placed on the market and the authorisation process 
along with relevant legislation and guidance is available on the EU Commission website12. Irish 
food law clearly requires that food supplements destined for the Irish market must be notified 
to the FSAI. Unauthorised nutrition and health claims, medicinal claims and misleading 
labelling claims are not permitted in line with the relevant pieces of EU and Irish legislation. 
The discrepancies between declared and analytical levels of CBD in foods has been highlighted 
previously1. In this survey, sample analysis was carried out by an Irish official control 
laboratory using an accredited method. Natural variation as well as the type and timing of 
cultivation, harvesting and processing can all influence the level of the various cannabinoids 
in Cannabis sativa. A slight variation between the analytical and declared CBD content of a 
sample could be attributed to deviations in laboratory handling and analytical methods used. 
However, some of the discrepancies identified in this survey suggest a significant problem 
with the general quality control of these products. 
The results of this survey revealed that 32 out of the 38 samples tested (84%) contained 
detectable levels of ∆9-THC. Using the maximum stated dosage provided by the 
manufacturer, it was estimated that 14 of those 38 products (37%) could result in the acute 
reference dose set by EFSA3 being significantly exceeded. 
The relatively high levels of ∆9-THC in some products tested in this survey gives rise to 
immediate concern in relation to the EFSA-derived safety value. However, it is of more 
general concern when considering consumers who purchase these products for their CBD 
content, but who may subsequently encounter the physical and physiological effects 
associated with ingestion of the psychoactive ∆9-THC. 
Concern was expressed in a 2020 EFSA Opinion5 that the acute reference dose for THC could 
be exceeded by foods containing or consisting of hemp in the EU. This concern had already 
been highlighted in a 2018 report6 by the German Federal Institute for Risk Assessment (BfR) 
Survey: Regulatory Issues with Hemp-based Food and Food Supplements on the Irish Market 
Page | 10  
 
The Food Safety Authority of Ireland             Monitoring & Surveillance 
which concluded that THC levels were too high in many hemp-containing foods and that 
physical and health impairments were possible. The BfR report went on to explain: 
“Moreover, it also appears possible that the consumption of foods containing hemp might 
result in the intake of ∆9-THC doses in the range of the pharmaceutically administered doses 
of ≥ 2.5 mg per person and day. In this case, the occurrence of pharmacological effects must 
be expected. As psychomotor effects must also be expected in this dose range, consumption 
of hemp containing foods may also result in restrictions in a person’s ability to drive or operate 
a dangerous piece of machinery. The psychomotor effects can also be intensified by the 
consumption of alcohol and certain other drugs.” 
A number of products in this survey of the Irish market had the potential to deliver 
approximately 2.5mg of ∆9-THC in a day. According to the German report, this level of ∆9-THC 
could affect the motor skills of people driving or operating certain pieces of machinery. In the 
USA7,8,9 there have been reports of professional drivers losing their jobs following positive 
drug tests which they claim were due to the consumption of THC-contaminated CBD 
products. 
Sport Ireland has published an advisory notice on social media10 warning athletes of the 
possible risk of failing drug tests due to the consumption of CBD products which may contain 
varying levels of ∆9-THC and other cannabinoids. World Anti-Doping Agency (WADA) rules11 
stipulate that “All natural and synthetic cannabinoids are prohibited, except for Cannabidiol”. 
A considerable number of potential regulatory breaches have been identified from this survey 
of the Irish market. Accordingly, the FSAI is working with official agencies and the relevant 
food businesses to rectify all issues identified, with priority given to products that could pose 
a safety risk to consumers. Further work in examining this expanding range of Cannabis-based 
foods and food supplements for regulatory compliance is planned by the FSAI. 
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